Company intelligence / Profile preview

Sun Therapeutics

Mumbai, Maharashtra, Indiabehindthesuntherapeutics.com ↗

Ownership: Private
Employees: ~41000
Development stage: Other

Overview

Sun Pharma is the largest pharmaceutical company in India and among the top global specialty generic companies. It has a strong record of delivering billions of doses annually across chronic and acute therapies. Its R&D focuses on generics as well as technologically complex products such as liposomal drugs and controlled-release dosage forms. The company has an active pipeline in dermatology, ophthalmology, oncology and other areas with both generic and innovative products.

Therapeutic areas: NeurologyInfectious DiseasesDermatologyOphthalmologyGastroenterologyEndocrinologyOncologyImmunologyCardiovascular
Modalities: Small moleculeBiologicMonoclonal antibodyBiosimilarLiposomal drug formulationsInhalersLyophilized injections
Industry: Pharma

Partnerships

Multiple international collaborationsRanbaxy acquisition notable

Beyond the preview

Go deeper on Sun Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sun Therapeutics.

Explore the full profile